Skip to main content
Spinal Cord Injuries (SCI)Healthy volunteersBrain and nervesMetabolicDevice

What this study is

This study evaluates the use of noninvasive transcutaneous spinal cord stimulation (tSCS) to improve glucose regulation and metabolic function in individuals with and without spinal cord injury (SCI) across a spectrum of metabolic states, including no diabetes, prediabetes, and type 2 diabetes (T2D).

What's being tested

  • Transcutaneous Spinal Cord Stimulation (tSCS)

    Intervention · DEVICE

    Noninvasive Transcutaneous Spinal Cord Stimulation (tSCS)

  • Sham transcutaneous spinal cord stimulation (tSCS)

    Intervention · DEVICE

    Inactive (sham) tSCS

Study details

Official title
Effects of Noninvasive Spinal Cord Neuromodulation on Metabolic Function
Sponsor
Rahul Sachdeva
Conditions
Spinal Cord Injuries (SCI) · Prediabetes / Type 2 Diabetes
Enrolling
120 people
Starts
2026-10-20
Est. completion
2030-12
Design
Single-blind, randomized, parallel groups
Record
View on ClinicalTrials.gov ↗